• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Ia类和Ib类抗心律失常药物的分子建模——不同结合受体的模型概念]

[Molecular modeling of anti-arrhythmia agents in class Ia and Ib--model conceptions of different binding receptors].

作者信息

Marrer S

出版信息

Pharm Acta Helv. 1989;64(12):338-44.

PMID:2616583
Abstract

The molecular properties of quinidine, EO 122, and lidocaine were investigated using theoretical methods (Molecular Modeling). The binding pattern of the molecules were investigated by calculating interaction energies with a negative charged fragment (receptor model). Based on these calculations a model for the differentiation of class Ia and class Ib antiarrhythmic drugs could be deduced. The results explain data which were formulated in the modulated receptor hypothesis. In this way the molecular basis for the preferred affinity of quinidine to the open state of the sodium channel as well as the equal affinity of lidocaine to the open and inactivated state of the channel were defined.

摘要

使用理论方法(分子建模)研究了奎尼丁、EO 122和利多卡因的分子特性。通过计算与带负电荷片段(受体模型)的相互作用能来研究分子的结合模式。基于这些计算,可以推导出区分I a类和I b类抗心律失常药物的模型。结果解释了在调制受体假说中阐述的数据。通过这种方式,确定了奎尼丁对钠通道开放状态的优先亲和力以及利多卡因对通道开放和失活状态的同等亲和力的分子基础。

相似文献

1
[Molecular modeling of anti-arrhythmia agents in class Ia and Ib--model conceptions of different binding receptors].[Ia类和Ib类抗心律失常药物的分子建模——不同结合受体的模型概念]
Pharm Acta Helv. 1989;64(12):338-44.
2
Pharmacophore and pseudoreceptor modelling of class Ib antiarrhythmic and local anaesthetic lidocaine analogues.Ib类抗心律失常药及局部麻醉药利多卡因类似物的药效团和伪受体建模
Pharmazie. 1998 Sep;53(9):596-602.
3
The cutaneous analgesic effect of class I antiarrhythmic drugs.I类抗心律失常药物的皮肤镇痛作用。
Anesth Analg. 2007 Apr;104(4):955-8. doi: 10.1213/01.ane.0000256882.13617.ad.
4
Mechanistic aspects of benzothiazepines: a class of antiarrhythmic drugs.苯并噻氮䓬类药物的作用机制:一类抗心律失常药物。
Eur J Med Chem. 2009 Jan;44(1):1-6. doi: 10.1016/j.ejmech.2008.03.002. Epub 2008 Mar 12.
5
A model study of time- and voltage-dependent effects of class I antiarrhythmic drugs in guinea-pig papillary muscles as related to external potassium concentration.与细胞外钾离子浓度相关的I类抗心律失常药物对豚鼠乳头肌时间和电压依赖性影响的模型研究
Arzneimittelforschung. 1994 Aug;44(8):929-37.
6
EO-199, a specific antagonist of antiarrhythmic drugs: assessment by binding experiments and in vivo studies.
Life Sci. 1991;48(10):977-85. doi: 10.1016/0024-3205(91)90363-g.
7
Negative dromotropic effects of class I antiarrhythmic drugs in anisotropic ventricular muscle.I类抗心律失常药物对各向异性心室肌的负性变传导作用
Cardiovasc Res. 1996 Apr;31(4):640-50.
8
Inhibition of human liver cytochrome P-450 1A2 by the class IB antiarrhythmics mexiletine, lidocaine, and tocainide.ⅠB类抗心律失常药美西律、利多卡因和妥卡尼对人肝脏细胞色素P-450 1A2的抑制作用。
J Pharmacol Exp Ther. 1999 May;289(2):853-8.
9
Evaluation of negative inotropic and antiarrhythmic effects of class 1 antiarrhythmic drugs.Ⅰ类抗心律失常药物的负性肌力和抗心律失常作用评估。
Int J Clin Pharmacol Ther. 1994 Jul;32(7):347-55.
10
Antiarrhythmic drugs inhibit the G-protein and K+ channels in the cultured thyroid cell line.
J Pharmacol Exp Ther. 1995 May;273(2):702-8.